New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 30, 2017 – Several manufacturers received FDA approval for AB-rated generic versions of Eli Lilly’s Strattera (atomoxetine).
Download PDF
Return to publications
